‘Driven out by middlemen’: Pharmacists across Kansas advocating for reform
Hundreds of Kansas pharmacies are working to make their message clear: They need pharmacy benefit manager (PBM) reforms.
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.